Reference
Tremblay G, et al. The Cost-Effectiveness of Eltrombopag for the Treatment of Immune Thrombocytopenia in the United States. Clinical Therapeutics : 18 Mar 2020. Available from: URL: https://doi.org/10.1016/j.clinthera.2020.02.020
Rights and permissions
About this article
Cite this article
Eltrombopag cost effective for immune thrombocytopenia. PharmacoEcon Outcomes News 850, 20 (2020). https://doi.org/10.1007/s40274-020-6708-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6708-6